Cancer is a mitochondrial metabolic disease driven by impaired respiration and compensatory glucose/glutamine fermentation, not primarily nuclear mutations. Management centers on press-pulse metabolic therapy: lowering glucose and glutamine, raising ketones, and combining diet, fasting, hyperbaric oxygen, and targeted drug pulses.
A presentation by Professor Thomas Seyfried recorded during the March 2026 Grand Rounds of the Australasian Metabolic Health Society
summerizer
Mitochondrial origin of cancer
- The mitochondrial-metabolic model links cancer to chronic damage in oxidative phosphorylation as the origin of malignant behavior.
- The somatic mutation theory is weakened by tumor nuclei regaining regulated growth in normal cytoplasm, while tumor cytoplasm drives death or dysregulated growth.
- Nuclear-transfer experiments in frogs, medulloblastoma mice, and melanoma mice place the decisive cancer defect outside the nucleus.
- The National Cancer Institute definition keeps cancer inside a genetic-disease view, while the lecture places the core defect in mitochondrial energy production.
Energy metabolism and tumor growth
- Warburg identified insufficient respiration and compensatory fermentation through glucose-derived lactate.
- Glutamine fermentation adds a second major fuel stream, producing succinate in damaged mitochondria.
- Glucose and glutamine supply ATP, carbons, and nitrogen for membranes, proteins, nucleotides, lipids, and other biomass.
- Lactic and succinic acid create an acidic microenvironment that supports invasion and weakens drug and immune effects.
- Reactive oxygen species arise downstream from damaged respiration and can produce the mutations seen in tumor genomes.
Cancer hallmarks from damaged mitochondria
- Cell-cycle disorder follows mitochondrial effects on nuclear gene expression and regulatory control.
- Loss of contact inhibition follows calcium and adhesion defects at the tumor-cell surface.
- Angiogenesis follows HIF-1 alpha and c-MYC opening glucose and glutamine transport pathways.
- Failed apoptosis follows dysfunction in the organelle that normally controls programmed cell death.
- Metastasis follows fusion between a cancer stem cell and a macrophage-like immune cell, creating a mobile glucose- and glutamine-driven cell.
Metabolic management strategy
- Management requires lowering glucose and glutamine while raising fatty acids and ketones.
- Cancer cells cannot rely on fatty acids or ketone bodies when glucose and glutamine are unavailable.
- Water-only fasting, calorie restriction, low-carbohydrate diets, ketogenic diets, ketone supplements, exercise, stress control, hyperbaric oxygen, and pulse drugs fit this strategy.
- The glucose ketone index tracks the glucose-to-ketone ratio, with values near or below 2.0 used as the therapeutic zone.
- Press-pulse therapy uses chronic metabolic pressure plus timed pulses against glucose and glutamine dependence.
Preclinical evidence
- In an aggressive mouse brain-tumor model, 40% calorie restriction on the same high-carbohydrate diet reduced tumor size by 65% to 80%.
- Higher blood glucose tracked with larger and faster tumors, while lower glucose tracked with slower tumor growth, lower inflammation, fewer abnormal vessels, and more tumor killing.
- Calorie-restricted ketogenic diet plus pulsed DON produced far better survival in late-stage experimental glioblastoma than either diet or DON alone.
- A juvenile high-grade glioma model used restricted ketogenic diet, mebendazole, and glucose-glutamine targeting, with longer survival and better quality of life.
Human and animal cases
- Glioblastoma outcomes have barely improved, and standard surgery, radiation, chemotherapy, and steroids can increase glucose, glutamine, inflammation, and metabolic stress.
- The Alexandria glioblastoma case combined fasting, restricted ketogenic diet, awake craniotomy, modified standard care, and hyperbaric oxygen, with 24-month follow-up publication.
- Brittany Maynard is used as a standard-care contrast case: young glioblastoma patient, steroid effects, and medically assisted death in 2014.
- Pablo Kelly used ketogenic metabolic therapy without chemotherapy or radiation, tracked glucose and ketones for years, and lived 122 months after diagnosis.
- The Greece glioblastoma study pairs standard care with ketogenic metabolic therapy; four of six adherent patients lived at least three years versus one of twelve in the standard-care group.
- Triple-negative breast cancer, lung cancer, prostate cancer, and canine mast-cell tumor examples are used as broader applications of the same metabolic strategy.
Closing thesis
- Cancer management should avoid fatalistic terminal language when metabolic options remain.
- Mitochondria, not the nucleus, belong at the center of cancer origin and management.
- Substrate-level phosphorylation through glucose and glutamine fermentation drives dysregulated growth.
- The future cancer program is press-pulse metabolic therapy: lower glucose and glutamine, elevate ketones, and use coordinated metabolic tools.
References
- [00:00] Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer — https://doi.org/10.1002/9781118310311
- [02:00] Can the Mitochondrial Metabolic Theory Explain Better the Origin and Management of Cancer than Can the Somatic Mutation Theory? — https://doi.org/10.3390/metabo11090572
- [03:00] Hallmarks of Cancer: The Next Generation — https://doi.org/10.1016/j.cell.2011.02.013
- [06:00] Transplantation of Pluripotential Nuclei from Triploid Frog Tumors — https://doi.org/10.1126/science.165.3891.394
- [07:00] Mouse Embryos Cloned from Brain Tumors — https://aacrjournals.org/cancerres/article/63/11/2733/510012/Mouse-Embryos-Cloned-from-Brain-Tumors1
- [08:00] Reprogramming of a Melanoma Genome by Nuclear Transplantation — https://doi.org/10.1101/gad.1213504
- [10:00] What Is Cancer? — https://www.cancer.gov/about-cancer/understanding/what-is-cancer
- [11:00] On the Origin of Cancer Cells — https://doi.org/10.1126/science.123.3191.309
- [18:00] The Living State and Cancer — https://doi.org/10.1073/pnas.74.7.2844
- [21:00] Cancer as a Metabolic Disease — https://doi.org/10.1186/1743-7075-7-7
- [21:00] Cancer as a Metabolic Disease: Implications for Novel Therapeutics — https://doi.org/10.1093/carcin/bgt480
- [21:00] Cancer as a Mitochondrial Metabolic Disease — https://doi.org/10.3389/fcell.2015.00043
- [22:00] The Calorically Restricted Ketogenic Diet, an Effective Alternative Therapy for Malignant Brain Cancer — https://doi.org/10.1186/1743-7075-4-5
- [23:00] The Glucose Ketone Index Calculator: A Simple Tool to Monitor Therapeutic Efficacy for Metabolic Management of Brain Cancer — https://doi.org/10.1186/s12986-015-0009-2
- [25:00] Press-Pulse: A Novel Therapeutic Strategy for the Metabolic Management of Cancer — https://doi.org/10.1186/s12986-017-0178-2
- [26:00] Therapeutic Benefit of Combining Calorie-Restricted Ketogenic Diet and Glutamine Targeting in Late-Stage Experimental Glioblastoma — https://doi.org/10.1038/s42003-019-0455-x
- [29:00] Management of Glioblastoma Multiforme in a Patient Treated With Ketogenic Metabolic Therapy and Modified Standard of Care: A 24-Month Follow-Up — https://doi.org/10.3389/fnut.2018.00020
- [30:00] Terminally Ill Woman Brittany Maynard Has Ended Her Own Life — https://people.com/celebrity/terminally-ill-woman-brittany-maynard-has-ended-her-own-life/
- [31:00] Ketogenic Metabolic Therapy, Without Chemo or Radiation, for the Long-Term Management of IDH1-Mutant Glioblastoma: An 80-Month Follow-Up Case Report — https://doi.org/10.3389/fnut.2021.682243
- [33:00] Successful Application of Dietary Ketogenic Metabolic Therapy in Patients With Glioblastoma: A Clinical Study — https://doi.org/10.3389/fnut.2024.1489812
- [35:00] Ketogenic Diet as a Metabolic Vehicle Enhancing the Therapeutic Efficacy of Mebendazole and Devimistat in Juvenile Syngeneic High-Grade Glioma — https://doi.org/10.1016/j.xcrm.2026.102845
- [35:00] Efficacy of Metabolically Supported Chemotherapy Combined With Ketogenic Diet, Hyperthermia, and Hyperbaric Oxygen Therapy for Stage IV Triple-Negative Breast Cancer — https://doi.org/10.7759/cureus.1445
- [36:00] Restricted Ketogenic Diet Therapy for Primary Lung Cancer With Metastasis to the Brain: A Case Report — https://doi.org/10.7759/cureus.27603
- [36:00] Clinical Research Framework Proposal for Ketogenic Metabolic Therapy in Glioblastoma — https://doi.org/10.1186/s12916-024-03775-4
- [37:00] Case Report: Resolution of Malignant Canine Mast Cell Tumor Using Ketogenic Metabolic Therapy Alone — https://doi.org/10.3389/fnut.2023.1157517
It’s definitely interesting and I’ll keep an eye on it. I still think Seyfried’s way overstating his case and there’s a lot of potential for bad outcomes from it, especially in the current climate around medicine.
I don’t see any downsides to people reducing glucose when they are worried about cancer.
As far as the KMT, it should be combined with a physician anyway, so not much risk of people doing it DIY since the drugs are prescription only.
As far as downvotes in this community go - downvotes are not a disagree button, it’s a signal something is bad for the community. downvoting a interesting post you want to keep your eye on future developments of sends me mixed signal.
The downvcote is because I think this is a bad video to communicate this area of research. As I’ve said, Seyfried’s claims are way over the top and I don’t think accurately inform on the science.